Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit Monoclonal Primary Antibody test. This test is now the first ...
FDA-approved monograph doesn’t say non-drowsy label required Suit is part of wave of litigation over DXM in cold medicines CVS Pharmacy Inc. failed to convince a federal judge that federally approved ...